Cassava Sciencesincis A Clinical Stage Biopharmaceutical Company Located In Austintexasspecializing In Neuroscienceoriginally Founded As Pain Therapeuticsincin 1998The Company Shifted Its Focus To Developing Treatments For Alzheimer S Disease And Rebranded As Cassava Sciences In 2019 The Company Is Dedicated To Creating Innovative Drugs For Neuroinflammation In Neurodegenerative Diseasesits Lead Productsimufilamis An Oral Treatment For Alzheimer S Disease Dementiacurrently Undergoing Two Phase Iii Clinical Trialsadditionallycassava Sciences Is Developing Savadxa Diagnostic Tool That Detects Alzheimer S Disease From A Small Blood Samplewhich Is In The Research Phase With A Small Team Of Around 30 Employeescassava Sciences Is Publicly Traded And Actively Engaged In Clinical Trials And Product Development
